We have just obtained the official valuation report for our intellectual property, namely the breakthrough CGM technology developed under the MLC project for the Chinese market!
What has been valuated?
Not just a product, but exclusive rights, know-how and technology solutions protected by patents. This is the groundwork for future products and their monetization!
The estimated total valuation amounts to $ 108,201,000!
And that's just for China, because as certification expands to other regions, the value of the intellectual property will grow.
Why is this important to investors?
- Proven value of technology reduces risks
- Intellectual property rights secure long-term monetization
- Now is the last chance to join the project at the pre-marketing stage
Technology shares are still available, but not for long!
We didn't just create value, we measured it. The next step is scaling up and going global.
This estimate is more than just numbers. This is a confirmation of the market outlook for our technology and a signal to investors: the right time to join the project with maximum profit is now. Hurry up and capture your share of the technology that will continue growing in value!
View the technology valuation by following the link: https://mail-cdn.mlc.health/doc/Valuation_report_MLCGT_CGM_Technologies_april_10_2025.pdf
